nach oben

Erschienen in:

2017 | OriginalPaper | Buchkapitel

6. Bedeutung immunologischer Prozesse im 2./3. Trimenon

verfasst von : Aurelia Vattai, Udo Jeschke

Erschienen in: Fehlgeburten Totgeburten Frühgeburten

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Störungen immunologischer Prozesse während der Schwangerschaft können Präeklampsien, HELLP-Syndrome, intrauterine Wachstumsretardierungen sowie Fehl- und Frühgeburten verursachen. Es werden verschiedene Proteine und Hormone beschrieben, deren Dysregulation eine Schwangerschaft gefährden können. Zudem werden Marker genannt, die auf einen pathologischen Schwangerschaftsverlauf hinweisen.

Abrahams VM et al. (2004) Macrophages and apoptotic cell clearance during pregnancy. Am J Reprod Immunol 51(4): 275–282PubMedCrossRef

Alijotas-Reig J, Llurba E, Gris JM (2014) Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells. Placenta 35(4): 241–248PubMedCrossRef

Almkvist J, Karlsson A (2004) Galectins as inflammatory mediators. Glycoconj J 19(7-9): 575–581PubMedCrossRef

Areia A et al. (2015) Can membrane progesterone receptor alpha on T regulatory cells explain the ensuing human labour? J Reprod Immunol 113: 22–26PubMedCrossRef

Auvynet C et al. (2013) Galectin-1 promotes human neutrophil migration. Glycobiology 23(1): 32–42PubMedCrossRef

Bamberger AM et al. (1997) Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab 82(9): 3173–3175PubMedCrossRef

Baumann R (2010) Physiologie. Thieme, Stuttgart

Bianchi DW et al. (1996) Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 93(2): 705–708PubMedPubMedCentralCrossRef

Blidner AG, Rabinovich GA (2013) ‚Sweetening‘ pregnancy: galectins at the fetomaternal interface. Am J Reprod Immunol 69(4): 369–382PubMedCrossRef

Bozic M et al. (2004) Galectin-1 and galectin-3 in the trophoblast of the gestational trophoblastic disease. Placenta 25(10): 797–802PubMedCrossRef

Brune T et al. (2004) The increased lysis of fetal cells in the mother after pregnancies complicated by pre-eclampsia or HELLP syndrome is not the result of a specific anti-fetal cytotoxicity of the mother. Am J Reprod Immunol 51(2): 174–179PubMedCrossRef

Canellada A et al. (2002) Interleukin regulation of asymmetric antibody synthesized by isolated placental B cells. Am J Reprod Immunol 48(4): 275–282PubMedCrossRef

Canellada A et al. (2002) In vitro modulation of protective antibody responses by estrogen, progesterone and interleukin-6. Am J Reprod Immunol 48(5): 334–343PubMedCrossRef

Cannon JG (2000) Inflammatory cytokines in nonpathological states. News Physiol Sci 15: 298–303PubMed

Challis JR, Smith SK (2001) Fetal endocrine signals and preterm labor. Biol Neonate 79(3-4): 163–167PubMedCrossRef

Chernyshov VP et al. (2008) Th1 and Th2 in human IVF pregnancy with allogenic fetus. Am J Reprod Immunol 59(4): 352–358PubMedCrossRef

Damsker JM, Hansen AM, Caspi RR (2010) Th1 and Th17 cells: adversaries and collaborators. Ann N Y Acad Sci 1183: 211–221PubMedPubMedCentralCrossRef

Dautzenberg FM, Hauger RL (2002) The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 23(2): 71–77PubMedCrossRef

Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129(6): 1339–1350PubMedCrossRef

Garin MI et al. (2007) Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood 109(5): 2058–2065PubMedCrossRef

Gil CD, Gullo CE, Oliani SM (2010) Effect of exogenous galectin-1 on leukocyte migration: modulation of cytokine levels and adhesion molecules. Int J Clin Exp Pathol 4(1): 74–84PubMedPubMedCentral

Hauger RL et al. (2006) Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets 5(4): 453–479PubMedPubMedCentralCrossRef

Hillhouse EW, Grammatopoulos DK (2002) Role of stress peptides during human pregnancy and labour. Reproduction 124(3): 323–329PubMedCrossRef

Hillier SL et al. (1991) Microbiologic causes and neonatal outcomes associated with chorioamnion infection. Am J Obstet Gynecol 165(4 Pt 1): 955–961PubMedCrossRef

Hobel CJ et al. (1999) Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks' gestation in pregnancies ending in preterm delivery. Am J Obstet Gynecol 180(1 Pt 3): S257–263CrossRef

van der Hoorn ML (2010) Clinical and immunologic aspects of egg donation pregnancies: a systematic review. Hum Reprod Update 16(6): 704–712PubMedCrossRef

van der Hoorn ML et al. (2014) Differential immunoregulation in successful oocyte donation pregnancies compared with naturally conceived pregnancies. J Reprod Immunol 101-102: 96–103PubMedCrossRef

Iwakura Y, Ishigame H (2006) The IL-23/IL-17 axis in inflammation. J Clin Invest 116(5): 1218–1222PubMedPubMedCentralCrossRef

Jacobsson B, Mattsby-Baltzer I, Hagberg H (2005) Interleukin-6 and interleukin-8 in cervical and amniotic fluid: relationship to microbial invasion of the chorioamniotic membranes BJOG 112(6): 719–724PubMedCrossRef

Jeschke U et al. (2005) Expression of glycodelin A in decidual tissue of preeclamptic, HELLP and intrauterine growth-restricted pregnancies. Virchows Arch 446(4): 360–368PubMedCrossRef

Jeschke U et al. (2007) Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas. Placenta 28(11–12): 1165–1173PubMedCrossRef

Jeschke U et al. (2013) Expression and function of galectins in the endometrium and at the human feto-maternal interface. Placenta 34(10): 863–872PubMedCrossRef

Jiang TT et al. (2014) Regulatory T cells: new keys for further unlocking the enigma of fetal tolerance and pregnancy complications. J Immunol 192(11): 4949–4956PubMedPubMedCentralCrossRef

Kalantaridou SN et al. (2003) Roles of reproductive corticotropin-releasing hormone. Ann N Y Acad Sci 997: 129–135PubMedCrossRef

Karteris E et al. (2003) Reduced expression of corticotropin-releasing hormone receptor type-1 alpha in human preeclamptic and growth-restricted placentas. J Clin Endocrinol Metab 88(1): 363–370PubMedCrossRef

Karteris E et al. (2005) Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides. J Clin Endocrinol Metab 90(6): 3680–3687PubMedCrossRef

Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21(4): 467–476PubMedCrossRef

Koopman LA et al. (2003) Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 198(8): 1201–1212PubMedPubMedCentralCrossRef

Kopcow HD et al. (2008) T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1. Proc Natl Acad Sci U S A 105(47): 18472–18477PubMedPubMedCentralCrossRef

Kovacs-Solyom F et al. (2010) Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1. Immunol Lett 127(2): 108–118PubMedCrossRef

Kubach J et al. (2007) Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. Blood 110(5): 1550–1558PubMedCrossRef

Lange F et al. (2009) Galectin-1 induced activation of the mitochondrial apoptotic pathway: evidence for a connection between death-receptor and mitochondrial pathways in human Jurkat T lymphocytes. Histochem Cell Biol 132(2): 211–223PubMedCrossRef

Makrigiannakis A et al. (2001) Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat Immunol 2(11): 1018–1024PubMedCrossRef

Makrigiannakis A et al. (2007) Maternal serum corticotropin-releasing hormone and ACTH levels as predictive markers of premature labor. Int J Gynaecol Obstet 97(2): 115–159PubMedCrossRef

Maquoi E et al. (1997) Changes in the distribution pattern of galectin-1 and galectin-3 in human placenta correlates with the differentiation pathways of trophoblasts. Placenta 18(5-6): 433–439PubMedCrossRef

Martinez-Varea A et al. (2014) Relationship between maternal immunological response during pregnancy and onset of preeclampsia. J Immunol Res 2014: 210–241CrossRef

Maynard SE et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111(5): 649–658PubMedPubMedCentralCrossRef

Minas V et al. (2007) Abortion is associated with increased expression of FasL in decidual leukocytes and apoptosis of extravillous trophoblasts: a role for CRH and urocortin. Mol Hum Reprod 13(9): 663–673PubMedCrossRef

Molvarec A et al. (2015) Increased circulating interleukin-17 levels in preeclampsia. J Reprod Immunol 112: 53–57PubMedCrossRef

Perone MJ et al. (2009) Suppression of autoimmune diabetes by soluble galectin-1. J Immunol 182(5): 2641–2653PubMedPubMedCentralCrossRef

Petsas G et al. (2012) Aberrant expression of corticotropin-releasing hormone in pre-eclampsia induces expression of FasL in maternal macrophages and extravillous trophoblast apoptosis. Mol Hum Reprod 18(11): 535–545PubMedCrossRef

Polgar B et al. (2004) Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome. Biol Reprod 71(5): 1699–1705PubMedCrossRef

Rees LH et al. (1975) Possible placental origin of ACTH in normal human pregnancy. Nature 254(5501): 620–622PubMedCrossRef

Reiner SL (2007) Development in motion: helper T cells at work. Cell 129(1): 33–36PubMedCrossRef

Reister F et al. (1999) The distribution of macrophages in spiral arteries of the placental bed in pre-eclampsia differs from that in healthy patients. Placenta 20(2–3): 229–233PubMedCrossRef

Reister F et al. (2001) Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 81(8): 1143–1152PubMedCrossRef

Romero R et al. (1993) Amniotic fluid interleukin-6 determinations are of diagnostic and prognostic value in preterm labor. Am J Reprod Immunol 30(2–3): 167–183PubMedCrossRef

Romero R et al. (2012) Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 206(2): 124 e1–19PubMedCrossRef

Saito S et al. (2007) Inadequate tolerance induction may induce pre-eclampsia. J Reprod Immunol 76(1–2): 30–39PubMedCrossRef

Sasaki A et al. (1988) Isolation and characterization of a corticotropin-releasing hormone-like peptide from human placenta. J Clin Endocrinol Metab 67(4): 768–773PubMedCrossRef

Schlembach D, Lang U (2008) Preeclampsia and pregnancy-induced hypertension - diseases determined in the uterus? Gynakol Geburtshilfliche Rundsch 48(4): 225–230PubMedCrossRef

Schlembach SV, Klein E, Lapaire O, Ramoni A, Stepan H (2015) Der sFlt-1/PlGF-Quotient in Prädiktion und Diagnostik der Präeklampsie. Frauenarzt 56(10): 858–865

Sharma S (2014) Natural killer cells and regulatory T cells in early pregnancy loss. Int J Dev Biol 58(2–4): 219–229PubMedPubMedCentralCrossRef

Shevach EM (2001) Certified professionals: CD4(+)CD25(+) suppressor T cells. J Exp Med 193(11): F41–46PubMedPubMedCentralCrossRef

Somerset DA et al. (2004) Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 112(1): 38–43PubMedPubMedCentralCrossRef

Steinman L (2007) A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13(2): 139–145PubMedCrossRef

Szekeres-Bartho J, Wegmann TG (1996) A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol 31(1–2): 81–95PubMedCrossRef

Szekeres-Bartho J et al. (1985) The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity: II. Relationship between cytotoxicity and the cyclooxygenase pathway of arachidonic acid metabolism. Am J Reprod Immunol Microbiol 9(1): 19–22PubMedCrossRef

Szekeres-Bartho J et al. (1989) Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell Immunol 122(2): 281–294PubMedCrossRef

Szekeres-Bartho J et al. (1996) The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol 35(4): 348–351PubMedCrossRef

Tan C et al. (2010) Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site. J Immunol 185(11): 6795–6801PubMedPubMedCentralCrossRef

Than NG et al. (2008) Chorioamnionitis and increased galectin-1 expression in PPROM - an anti-inflammatory response in the fetal membranes? Am J Reprod Immunol 60(4): 298–311PubMedPubMedCentralCrossRef

Velez DR et al. (2008) Patterns of cytokine profiles differ with pregnancy outcome and ethnicity. Hum Reprod 23(8): 1902–1909PubMedCrossRef

Verlohren S et al. (2012) The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 206(1): 58 e1–8PubMedCrossRef

Weissenbacher T et al. (2013) Diagnostic biomarkers of pro-inflammatory immune-mediated preterm birth. Arch Gynecol Obstet 287(4): 673–685PubMedCrossRef

Williams Z et al. (2009) Foreign fetal cells persist in the maternal circulation. Fertil Steril 91(6): 2593–2595PubMedCrossRef

Winkler M, Rath W (1996) The role of cytokines in the induction of labor, cervical ripening and rupture of the fetal membranes. Z Geburtshilfe Neonatol 200(suppl 1): 1–12PubMed

Wong MT et al. (2010) Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol Cell Biol 88(6): 624–631PubMedPubMedCentralCrossRef

Titel: Bedeutung immunologischer Prozesse im 2./3. Trimenon
verfasst von: Aurelia Vattai
Udo Jeschke
Verlag: Springer Berlin Heidelberg
Buch: Fehlgeburten Totgeburten Frühgeburten
Print ISBN: 978-3-662-50423-9

Electronic ISBN: 978-3-662-50424-6

Copyright-Jahr: 2017
DOI: https://doi.org/10.1007/978-3-662-50424-6_6

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

6. Bedeutung immunologischer Prozesse im 2./3. Trimenon

Zusammenfassung

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Update Gynäkologie

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Update Gynäkologie